Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Gross Profit: 2018-2024

Historic Gross Profit for Sunshine Biopharma (SBFM) over the last 7 years, with Dec 2024 value amounting to $10.7 million.

  • Sunshine Biopharma's Gross Profit rose 7.24% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year increase of 21.44%. This contributed to the annual value of $10.7 million for FY2024, which is 27.95% up from last year.
  • According to the latest figures from FY2024, Sunshine Biopharma's Gross Profit is $10.7 million, which was up 27.95% from $8.3 million recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Gross Profit registered a high of $10.7 million during FY2024, and its lowest value of $45,563 during FY2020.
  • In the last 3 years, Sunshine Biopharma's Gross Profit had a median value of $8.3 million in 2023 and averaged $6.9 million.
  • Data for Sunshine Biopharma's Gross Profit shows a peak YoY soared of 1,434.03% (in 2022) over the last 5 years.
  • Sunshine Biopharma's Gross Profit (Yearly) stood at $45,563 in 2020, then soared by 142.73% to $110,596 in 2021, then soared by 1,434.03% to $1.7 million in 2022, then spiked by 391.53% to $8.3 million in 2023, then climbed by 27.95% to $10.7 million in 2024.